Article Title: Aktiia SA raises $42M for BP monitoring platform, rebrands to Hilo
Publication Date: Tue, 06 May 2025 12:00:00 -0400
As reported on the 6th of May 2025, Swiss medical technology company Aktiia SA has recently secured $42 million in an oversubscribed series B funding round. Concurrently, the company has announced a corporate rebranding, becoming Hilo. The company intends to utilize these recently acquired funds to drive forward their product innovation strategies, expand their operational reach into new markets, and further develop their blood pressure monitoring platform for enterprise use.
The sizeable Series B funding and the strategic rebranding to Hilo reflect the company’s confident growth trajectory. The new funding will boost the development of Hilo’s sophisticated blood pressure monitoring system, reinforcing the company’s focus on providing efficient, critical health insights. The rebranding to Hilo represents a fresh, strategic, forward-thinking approach, aligning the firm’s market presence with its ambition for tech-driven healthcare solutions.
The diligent effort toward product innovation, particularly to improve their blood pressure monitoring platform, reveals Hilo’s commitment to evolve its product line in line with rapidly changing healthcare tech trends. Demand for such innovations has surged, particularly given the increased global emphasis on remote patient monitoring due to the recent pandemics.
Moreover, Hilo’s expansion into new markets presents a vast opportunity for the company to tap into unexplored user bases and further solidify its market standing. The $42 million fundraising achievement combined with strategic global expansion could dramatically increase the company’s user base and revenue in the coming years.
In summary, Hilo’s successful Series B funding round and corporate rebranding signal a distinct and challenging period of growth and opportunity for the firm. These developments will likely interest investors seeking to capitalize on advancements in healthcare technologies and digital health platforms.
Stay tuned to Industry Informant for updates on Hilo’s product development and market expansion efforts, and for a continued source of trusted and timely information in the biotech industry.
